Trial Profile
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fasedienol (Primary)
- Indications Social phobia
- Focus Registrational; Therapeutic Use
- Sponsors Pherin Pharmaceuticals
- 30 Nov 2015 New trial record